{"DataElement":{"publicId":"3607839","version":"1","preferredName":"Dose-Limiting Adverse Event Assessment Yes No Indicator","preferredDefinition":"the indicator of yes/no related to result of unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with side effects of a drug.","longName":"3607838v1.0:3506068v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3607838","version":"1","preferredName":"Dose-Limiting Adverse Event Assessment","preferredDefinition":"information related to result of unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with side effects of a drug.","longName":"3607836v1.0:2233077v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"3607836","version":"1","preferredName":"Dose-Limiting Adverse Event","preferredDefinition":"Describes side effects of a drug or other treatment that are serious enough to prevent an increase in dose or level of that treatment.:Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.","longName":"C28014:C41331","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose-Limiting","conceptCode":"C28014","definition":"Describes side effects of a drug or other treatment that are serious enough to prevent an increase in dose or level of that treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBA25F26-D166-0ED0-E040-BB89AD4378E0","latestVersionIndicator":"Yes","beginDate":"2012-10-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2012-10-09","modifiedBy":"ONEDATA","dateModified":"2012-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233077","version":"1","preferredName":"Assessment","preferredDefinition":"The final result of a determination of the value, significance, or extent of.","longName":"C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F90B5E56-BAFE-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-08","modifiedBy":"ONEDATA","dateModified":"2005-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBA25F26-D174-0ED0-E040-BB89AD4378E0","latestVersionIndicator":"Yes","beginDate":"2012-10-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2012-10-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"},{"name":"DsLimitTox","type":"COG GDE Short Name","context":"COG"},{"name":"3607838v1.0:3506068v1.0","type":"USED_BY","context":"Alliance"},{"name":"NRG","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Dose limiting toxicity","type":"Preferred Question Text","description":"Dose limiting toxicity","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Grade 3 or 4 non-hematologic toxicity that does not resolve to baseline level after delaying the next dose by more than 2 weeks","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Did the patient experience any drug-related dose-limiting toxicities (DLTs) that were defined in the protocol?","url":null,"context":"CTEP"},{"name":"COG CRF TEXT 1","type":"Alternate Question Text","description":"Was the adverse event a dose-limiting toxicity?","url":null,"context":"CTEP"},{"name":"NRG_CRF text","type":"Alternate Question Text","description":"Was there dose limiting toxicity this cycle?","url":null,"context":"NRG"},{"name":"COG CRF Text","type":"Alternate Question Text","description":"Did patient experience a Hematologic DLT during this reporting period?","url":null,"context":"CTEP"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Has patient had a total of 2 or more DLTs since start of EPI Block 1?","url":null,"context":"COG"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Grade 3 alanine aminotransferase increased lasting longer than 4 consecutive days or a 2 grade increase from baseline","url":null,"context":"Alliance"},{"name":"CRF Text9","type":"Alternate Question Text","description":"Grade 3 platelet count decreased associated with a grade greater than or equal to 3 bleeding event","url":null,"context":"Alliance"},{"name":"CRF Text10","type":"Alternate Question Text","description":"Grade 3 electrocardiogram QT corrected interval prolonged with QTc interval greater than or equal to 501 msec on at least two separate ECGs","url":null,"context":"Alliance"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Grade greater than or equal to 2 blood bilirubin increased lasting longer than 14 consecutive days","url":null,"context":"Alliance"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Grade 3 vomiting lasting longer than 48 hours despite optimal antiemetic therapy","url":null,"context":"Alliance"},{"name":"CRF Text7","type":"Alternate Question Text","description":"Grade 3 diarrhea lasting longer than 48 hours despite optimal antidiarrheal therapy","url":null,"context":"Alliance"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Did the patient have a dose-limiting toxicity?","url":null,"context":"Alliance"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Grade 2 alanine aminotransferase increased and associated with a grade greater than or equal to 2 bilirubin elevation of any duration in the absence of liver metastases, a 2 grade increase from baseline, or not related to the patient's underlying malignancy","url":null,"context":"Alliance"},{"name":"CRF Text11","type":"Alternate Question Text","description":"Grade 4 alkaline phosphatase increased lasting longer than 7 consecutive days","url":null,"context":"Alliance"},{"name":"CRF Text12","type":"Alternate Question Text","description":"Grade 4 neutrophil count decreased lasting longer than 7 consecutive days","url":null,"context":"Alliance"},{"name":"CRF Text13","type":"Alternate Question Text","description":"Any other Grade 3 or higher adverse event","url":null,"context":"Alliance"},{"name":"COG CRF Text 14","type":"Alternate Question Text","description":"Did patient experience a dose-limiting toxicity?","url":null,"context":"COG"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"Was the adverse event a dose limiting toxicity (DLT)?","url":null,"context":"COG"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBA25F26-D186-0ED0-E040-BB89AD4378E0","latestVersionIndicator":"Yes","beginDate":"2012-10-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2012-10-09","modifiedBy":"KUMMEROA","dateModified":"2022-09-30","changeDescription":null,"administrativeNotes":"7/20/2022:fixed the box symbol in AQT.wz 2022.9.30 AQT added for ticket request CADSR0001559. ak","unresolvedIssues":null,"deletedIndicator":"No"}}